Munich Re is offering shareholders a record dividend of €24 per share for the 2025 financial year, a 20% jump from the prior year that translates into a juicy 4.7% yield at the current stock price. Yet the market’s verdict is unforgiving: the shares closed at €503.80 on Friday, marking a fresh 52-week low and a decline of almost 15% over the past twelve months.
The disconnect between the company’s generous capital returns and its flagging stock price reflects a deeper tension within the German reinsurance giant. While the group is pumping roughly €5.3 billion back to shareholders through dividends and buybacks — nearly 90% of last year’s net profit — the operating environment is turning hostile.
Currency headwinds are the most immediate concern. Munich Re books a significant portion of its premium income in US dollars, and the euro has strengthened sharply. At the start of 2025, one euro bought around $1.03; during the first quarter of 2026, the exchange rate hovered between $1.15 and $1.20. That swing directly squeezes revenues and earnings when translated back into euros.
The top line is also under pressure from deliberate portfolio pruning. At the key January 2026 renewal season, written premium volume fell 7.8% to €13.7 billion as Munich Re walked away from business that no longer met its return requirements. The strategy of underwriting discipline comes with short-term costs, and the market is pricing them in.
Against this backdrop, management is sticking to its full-year target of an IFRS net profit of €6.3 billion, a modest increase from the record €6.12 billion posted in 2025 — the fifth consecutive year the company has beaten its own guidance. But analysts warn that the combination of a strong euro and softening pricing in property-casualty reinsurance is eating into the buffer.
Should investors sell immediately? Or is it worth buying Münchener Rück?
The longer-term picture is framed by the “Ambition 2030” strategic programme. Munich Re aims to grow annual earnings by an average of 8% through the end of the decade and to lift the share of less cyclical business lines from roughly 50% of total income to 60%. Cost savings are a key lever: its ERGO primary insurance unit plans to cut around 1,000 jobs by 2030, mostly in repetitive roles such as call centres and claims processing that can be automated with artificial intelligence. Another 700 staff will be retrained. The goal is to achieve annual savings of €600 million by 2030, with €200 million targeted for this year alone.
Analyst opinions remain split on the stock’s valuation. Barclays rates Munich Re as “Overweight” with a price target of €606, suggesting significant upside from current levels. RBC’s Ben Cohen is more cautious, assigning a “Sector Perform” rating and cutting his target to €560, citing diminished room for earnings beats in the coming years.
All eyes now turn to the first-quarter results due on 12 May, which will serve as the first hard reality check for both the 2026 profit target and the strategic overhaul. Investors will be watching how deeply currency effects and the premium decline have cut into underlying operating performance. The report arrives alongside important US consumer price data on Tuesday, which could set the tone for interest rate expectations and ripple through the insurance sector.
For now, Munich Re’s hefty dividend provides a floor for patient shareholders, but the path back to its 52-week high of €605 looks steep. The shares have already lost 8% year to date, and the next few weeks will test whether the company’s disciplined approach can weather the immediate storm — or whether the ambitions of 2030 will have to be recalibrated along the way.
Ad
Münchener Rück Stock: Buy or Sell?! New Münchener Rück Analysis from May 10 delivers the answer:
The latest Münchener Rück figures speak for themselves: Urgent action needed for Münchener Rück investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 10.
Münchener Rück: Buy or sell? Read more here...
